Abstract
Many biologically active compounds are unsuitable for development as drugs due to their poor bioavailability. For hydrophilic compounds, modifications to increase lipophilicity can increase passive diffusion or increase uptake into the lymphatic system. Alternatively, improved bioavailability of hydrophilic drug candidates may be achieved by formulation with absorption promoters such as surfactants, penetration enhancers, or ion pairing agents. This approach to enhancing bioavailability also has the potential to widen the range of compound categories that can be used as chemical probes to study biological systems in cells and in vivo where membrane permeability would otherwise be a significant limitation. Lipidic amino acids, which combine the structural properties of lipids with those of α-amino acids, represent a relatively unexplored class of agents that can improve drug adsorption. This review discusses the potential of absorption promoters possessing lipoamino acids for improving drug bioavailability.
Keywords: Absorption promoter, dendrimers, drug bioavailability, drug delivery, ion pairing agents, lipoamino acids, penetration enhancers, hydrophilic compounds, lymphatic system, hydrophilic drug, chemical probes, biological systems in cells, Lipidic amino acids
Current Topics in Medicinal Chemistry
Title:Lipoamino Acids as Major Components of Absorption Promoters in Drug Delivery
Volume: 12 Issue: 14
Author(s): Zyta M. Ziora, Mark A. Blaskovich, Istvan Toth and Matthew A. Cooper
Affiliation:
Keywords: Absorption promoter, dendrimers, drug bioavailability, drug delivery, ion pairing agents, lipoamino acids, penetration enhancers, hydrophilic compounds, lymphatic system, hydrophilic drug, chemical probes, biological systems in cells, Lipidic amino acids
Abstract: Many biologically active compounds are unsuitable for development as drugs due to their poor bioavailability. For hydrophilic compounds, modifications to increase lipophilicity can increase passive diffusion or increase uptake into the lymphatic system. Alternatively, improved bioavailability of hydrophilic drug candidates may be achieved by formulation with absorption promoters such as surfactants, penetration enhancers, or ion pairing agents. This approach to enhancing bioavailability also has the potential to widen the range of compound categories that can be used as chemical probes to study biological systems in cells and in vivo where membrane permeability would otherwise be a significant limitation. Lipidic amino acids, which combine the structural properties of lipids with those of α-amino acids, represent a relatively unexplored class of agents that can improve drug adsorption. This review discusses the potential of absorption promoters possessing lipoamino acids for improving drug bioavailability.
Export Options
About this article
Cite this article as:
M. Ziora Zyta, A. Blaskovich Mark, Toth Istvan and A. Cooper Matthew, Lipoamino Acids as Major Components of Absorption Promoters in Drug Delivery, Current Topics in Medicinal Chemistry 2012; 12 (14) . https://dx.doi.org/10.2174/156802612802652448
DOI https://dx.doi.org/10.2174/156802612802652448 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
p53: An Attractive Therapeutic Target for Cancer
Current Medicinal Chemistry Prediction and Monitoring of Therapeutic Response by Molecular Imaging
Current Medical Imaging Chitosan and Quercetin: Potential Hand in Hand Encountering Tumors in Oral Delivery System
Current Pharmaceutical Design EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Current Cancer Drug Targets Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets Therapeutic Value of an Integrin Antagonist in Prostate Cancer
Current Drug Targets Mitochondrial Therapeutics for Cardioprotection
Current Pharmaceutical Design Dihydrocodeine as an Opioid Analgesic for the Treatment of Moderate to Severe Chronic Pain
Current Drug Metabolism Immune Checkpoint Inhibitors: Basics and Challenges
Current Medicinal Chemistry Therapeutic Drugs in Bone Loss-Associated Disorders: Clinical Outcomes and Challenges
Current Drug Targets Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents
Current Medicinal Chemistry Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Current Pharmaceutical Design Lectin Microarrays: A Powerful Tool for Glycan-Based Biomarker Discovery
Combinatorial Chemistry & High Throughput Screening Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Targeted Alpha Therapy with 213Bi
Current Radiopharmaceuticals Tuberculosis Treated by Multiple Drugs: An Overview
Current Drug Delivery Postoperative Thoracic Epidural Anesthesia in Gastrointestinal Surgery: Outcomes, Quality of Life, and Current Controversies
Current Drug Therapy MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers
Current Pharmaceutical Design The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design